Literature DB >> 19509095

Etanercept treatment in Sweet's syndrome with inflammatory arthritis.

Nicola L Ambrose, Anne Marie Tobin, Donough Howard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19509095     DOI： 10.3899/jrheum.080698

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  4 in total

1.  Histiocytoid Sweet syndrome successfully treated with etanercept.

Authors:  Ian T Watson; Isabel Haugh; Alexis R Gardner; M Alan Menter
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-05-09

2.  Sweet's syndrome with idiopathic thrombocythemia.

Authors:  Sebastian Kaszewski; Rafał Czajkowski; Franciszka Protas-Drozd; Waldemar Placek; Sebastian Jakubowski
Journal:  Postepy Dermatol Alergol       Date:  2014-02-25       Impact factor: 1.837

3.  Increase of a wide range of bioactive substances in an active phase of neuro-Sweet disease.

Authors:  Hiroi Kusaka; Katsuya Nagatani; Takeo Sato; Seiji Minota
Journal:  BMJ Case Rep       Date:  2020-04-08

Review 4.  Biologics in dermatology: an integrated review.

Authors:  Virendra N Sehgal; Deepika Pandhi; Ananta Khurana
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.